tiprankstipranks
Reviva Pharmaceuticals Holdings (RVPH)
NASDAQ:RVPH
US Market

Reviva Pharmaceuticals Holdings (RVPH) Income Statement

Compare
287 Followers

Reviva Pharmaceuticals Holdings Income Statement

Last quarter (Q3 2024), Reviva Pharmaceuticals Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Reviva Pharmaceuticals Holdings's net income was $-8.37M. See Reviva Pharmaceuticals Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Mar 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -724.74K$ 0.00
Operating Expenses
$ 39.50T$ 24.31M$ 10.10M$ 2.43M$ 376.86K
Depreciation and Amortization
$ 0.00$ 194.71K$ 236.56K$ 105.77K$ 846.00
EBITDA
$ -39.50T$ -24.11M$ -10.10M$ -2.33M$ -376.01K
Operating Income
$ -39.50T$ -24.31M$ -10.10M$ -2.43M$ -376.86K
Other Income/Expenses
$ 39.50T$ -11.91K$ 1.59M$ -1.35M$ -469.17K
Pretax Income
$ -39.24M$ -24.32M$ -8.52M$ -3.78M$ -846.03K
Net Income
$ -39.26T$ -24.34M$ -8.52M$ -3.78M$ -846.83K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.65$ -1.25$ -0.58$ -1.24$ -0.31
Diluted EPS
$ -1.65$ -1.25$ -0.58$ -1.24$ -0.31
Weighted Average Shares Outstanding
23.80M 19.52M 14.79M 3.06M 2.77M
Weighted Average Shares Outstanding (Diluted)
23.80M 19.52M 14.79M 3.06M 2.77M
Currency in USD

Reviva Pharmaceuticals Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis